An Open-Label Multicenter Phase 1 Study of E7046 in Subjects With Selected Advanced Malignancies

Trial Profile

An Open-Label Multicenter Phase 1 Study of E7046 in Subjects With Selected Advanced Malignancies

Recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs E 7046 (Primary)
  • Indications Bladder cancer; Breast cancer; Cervical cancer; Colorectal cancer; Head and neck cancer; Liver cancer; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Renal cell carcinoma; Solid tumours; Squamous cell cancer
  • Focus Adverse reactions
  • Sponsors Eisai Inc
  • Most Recent Events

    • 12 Sep 2017 Results (n=30) presented at the 42nd European Society for Medical Oncology Congress
    • 31 Aug 2017 According to an Eisai Inc media release, the company will present the new clinical data from this trial at European Society of Medical Oncology (ESMO) 2017.
    • 09 Aug 2016 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top